VRNA - Verona Pharma PLC ADR (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-10    (Delayed quote data   2025-01-06)
Last
 44.81		 Change
 ⇓ -1.78   (-3.82%)		 Volume
  1,102,199
Open
 46.51		 High
 46.54		 Low
 44.62
8EMA (Daily)
 45.74		 40EMA (Daily)
 41.17		 50EMA (Daily)
 40.04		 STO (Daily)
 82.204		 MACD Hist (Daily)
 0.132
8EMA (Weekly)
 42.525		 40EMA (Weekly)
 30.64		 50EMA (Weekly)
 28.71		 STO (Weekly)
 89.868		 MACD Hist (Weekly)
 1.238
Company Profile
Verona Pharma PLC is a clinical-stage biopharmaceutical company. It is known for developing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com